JUVENILE POLYMYOSITIS
Clinical trials for JUVENILE POLYMYOSITIS explained in plain language.
Never miss a new study
Get alerted when new JUVENILE POLYMYOSITIS trials appear
Sign up with your email to follow new studies for JUVENILE POLYMYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells aim to tame rare muscle disorders
Disease control Recruiting nowThis study tests a new treatment called CABA-201 for people with active inflammatory myopathy, a group of rare diseases where the immune system attacks muscles. The treatment uses a patient's own immune cells, modified to target and destroy certain immune cells that cause the dis…
Matched conditions: JUVENILE POLYMYOSITIS
Phase: PHASE2, PHASE3 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Scientists hunt for environmental triggers of rare muscle disease
Knowledge-focused Recruiting nowThis study looks at whether certain environmental exposures—like infections, stress, or sun exposure—are more common in people with anti-synthetase syndrome (a type of myositis with lung involvement) compared to other myositis patients and healthy volunteers. Researchers will col…
Matched conditions: JUVENILE POLYMYOSITIS
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC